The Manila Times8h
Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden
Vigil is the first cellular immunotherapy to demonstrate longer-term survival benefits in a randomized controlled trial of patients with solid tumors. The results of the company's Phase 2b study have ...
The Sacramento Observer14h
Weekly Outings With The OBSERVER
OBSERVER Staff Writer - Featured Events Include Talks And Lectures, Dance Parties, Comedy Shows, Bingo/Game Nights And More ...